Rasmussen's encephalitis is a rare and progressive neurological disorder that primarily affects children. It is characterized by inflammation and damage to one hemisphere of the brain, leading to seizures, cognitive decline, and neurological deficits. The exact cause of Rasmussen's encephalitis is unknown, but it is believed to involve an autoimmune response, where the body's immune system mistakenly attacks healthy brain tissue.
Symptoms: The condition typically starts with focal seizures that become more frequent and severe over time. These seizures may be accompanied by weakness, loss of motor skills, language difficulties, and behavioral changes. As the disease progresses, individuals may experience hemiparesis (weakness on one side of the body), hemianopia (loss of vision on one side), and cognitive impairment.
Treatment: Currently, there is no cure for Rasmussen's encephalitis. However, early intervention with antiepileptic medications and immunomodulatory therapies can help manage seizures and slow down the progression of the disease. In severe cases, surgical interventions such as hemispherectomy (removal of the affected hemisphere) may be considered to control seizures and improve quality of life.
It is crucial for individuals with Rasmussen's encephalitis to receive comprehensive medical care and support from a multidisciplinary team of healthcare professionals to address their specific needs and optimize their overall well-being.